Peanut Allergy (PA) Epidemiology Forecast 2025-2034

Recent studies indicate that around 2% of the general population of Western nations is affected by peanut allergy, with the patients experiencing a substantial burden of self-management to prevent any accidental peanut exposure. It is also estimated that nearly 7% to 14% of patients with peanut allergy face accidental peanut exposure every year.

Peanut Allergy (PA) Epidemiology Forecast Report Coverage

The “Peanut Allergy (PA) Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of peanut allergy (PA). It projects the future incidence and prevalence rates of peanut allergy (PA) across various populations. The study covers age and gender as major determinants of the peanut allergy (PA)-affected population. The report highlights patterns in the prevalence of peanut allergy (PA) over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of peanut allergy (PA) in the 8 major markets.

Regions Covered

• The United States
• EU-4 (Germany, France, Italy, Spain) and the United Kingdom
• Japan
• India

Peanut Allergy (PA): Disease Overview

Peanut allergy (PA) refers to a type of food allergy from peanuts, where the ingestion of peanuts can lead to a potentially life-threatening allergic reaction called anaphylaxis. When an individual with a peanut allergy consumes peanuts, immunoglobin E (IgE) antibodies are released by their immune system, leading to the release of chemicals like histamine and the appearance of allergic symptoms. Skin reactions, respiratory problems, and gastrointestinal issues are some of the symptoms of an allergic reaction to peanuts. People with peanut allergy require careful management and awareness to avoid accidental exposure to this food allergen.

Peanut Allergy (PA): Treatment Overview

Avoiding peanuts and any products containing peanuts is the most effective way to prevent allergic reactions. Patients with this condition are typically prescribed an epinephrine auto-injector such as EpiPen to use in case of anaphylaxis. Over-the-counter antihistamines are commonly used to treat mild allergic symptoms like hives or nasal congestion. Although not used as a first-line treatment, corticosteroids are also prescribed to manage inflammation after an allergic reaction.

Epidemiology

The Peanut allergy (PA) epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for Peanut Allergy (PA) by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for peanut allergy (PA) and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to a 2020 review article published in the European Journal of Allergy and Clinical Immunology, 2% of the general population in Western countries is affected by peanut allergy. It is also stated that around 7% to 14% of the patients experience accidental exposure to peanuts each year whereas one-third to one-half may be affected by anaphylaxis.
• A cross-sectional food allergy survey conducted by Warren, Christopher et al. (2021) revealed the self-reported peanut allergy as 2.9% among adults in the United States, with 1.8% of them having convincing peanut allergy. Further, more than 17% of adults affected by peanut allergy reported the onset of their condition in adulthood.
• Various studies suggest that peanut allergy usually occurs in early childhood. Unlike other food allergies such as egg, milk, wheat, and soy, peanut allergy persists into adulthood in roughly 75% to 80% of children.
• As per the European Anaphylaxis Registry, peanut is reported as a common cause of severe allergic reactions or anaphylaxis in children and young adults, eliciting approximately one-third of all food-related anaphylaxis cases in the pediatric group.

Country-wise Peanut Allergy (PA) Epidemiology

The peanut allergy (PA) epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of peanut allergy differs between countries due to factors such as cultural dietary practices, population genetics, family history, and environmental factors. Various studies also suggest that reduced exposure to microbes and pathogens in early childhood may increase the likelihood of developing food allergies. Thus, regions with higher hygiene standards such as Western countries may see higher allergy rates. For instance, 1 out of 50 children in the United States are reported to have a peanut allergy.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of peanut allergy (PA) based on several factors.
• Peanut Allergy (PA) Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India)
• The report helps to identify the patient population, the unmet needs of peanut allergy (PA) are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of peanut allergy (PA) epidemiology in the 8 major markets?
• What will be the total number of patients with peanut allergy (PA) across the 8 major markets during the forecast period?
• What was the country-wise prevalence of peanut allergy (PA) in the 8 major markets in the historical period?
• Which country will have the highest number of peanut allergy (PA) patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of peanut allergy (PA) during the forecast period of 2025-2034?
• What are the currently available treatments for peanut allergy (PA)?
• What are the disease risks, signs, symptoms, and unmet needs of peanut allergy (PA)?

This product will be delivered within 3-5 business days.